https://www.marketscreener.com/quote/stock/SYNDAX-PHARMACEUTICALS-IN-16725742/news/Syndax-Pharmaceuticals-Inc-Presents-Positive-Pediatric-Data-from-Pivotal-AUGMENT-101-Trial-of-Revu-46395452/?utm_source=telegram&utm_medium=social&utm_campaign=share